Immune-related adverse events up with checkpoint inhibitors

January 4, 2018

(HealthDay)—Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease, immune-related adverse events (irAEs), or both, events can often be managed without discontinuing CPIs, according to a review published online Jan. 2 in the Annals of Internal Medicine.

Noha Abdel-Wahab, M.D., Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a systematic review to summarize the evidence on associated with CPIs in patients with cancer and pre-existing autoimmune disease. Data were included from 123 patients identified in 49 publications.

The researchers found that 75 percent of the patients had exacerbations of pre-existing autoimmune disease, irAEs, or both. Patients with active and inactive disease did not differ in terms of adverse events. Fewer adverse events seemed to occur among patients receiving at initiation of CPI therapy than in those not receiving treatment. Most of the flares and irAEs were managed with corticosteroids; other immunosuppressive therapies were required by 16 percent. In more than half of the patients, adverse events improved without discontinuation of CPI therapy. Three died because of adverse events.

"Prospective longitudinal studies are needed to establish incidence of adverse events and evaluate risk-benefit ratios and patient preferences in this population," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further: Checkpoint inhibitors no less safe with radiation

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Checkpoint inhibitors no less safe with radiation

September 29, 2017
(HealthDay)—Immune-related adverse events (IRAEs), including pneumonitis, are not more common in patients with metastatic lung cancer who receive both immune checkpoint inhibitors (CPIs) and thoracic radiotherapy (TRT), ...

LAMA plus LABA tied to fewer exacerbations in stable COPD

October 4, 2017
(HealthDay)—Treatment with long-acting muscarinic antagonists (LAMA) plus long-acting β-agonists (LABA) is associated with fewer exacerbation events in patients with chronic obstructive pulmonary disease (COPD), according ...

Continuing statin after adverse Rx tied to lower cardiac risk

July 25, 2017
(HealthDay)—For patients with an adverse reaction to a statin, continued statin prescriptions are associated with lower incidence of cardiovascular events and death, according to a study published online July 25 in the ...

Melanoma therapy tied to cutaneous adverse events

March 16, 2016
(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...

Immune checkpoint inhibitor endocrine dysfunction explored

September 29, 2017
(HealthDay)—Patients receiving immune checkpoint inhibitor (ICI) regimens may experience endocrine dysfunction, with increased risk of thyroid dysfunction and hypophysitis for patients on combination therapy, according ...

Preemies have lasting risk for anesthesia adverse events

February 26, 2016
(HealthDay)—Preterm children have an increased risk of developing sedation/anesthesia adverse events, which continues up to age 23 years, according to a study published online Feb. 25 in Pediatrics.

Recommended for you

Fetal immune system rejects the mother in preterm labor

April 25, 2018
Preterm labor, a common pregnancy complication, has long been a mystery to scientists. But a new study from UC San Francisco shows it may sometimes happen when the fetal immune system "wakes up" too early and begins to reject ...

Immune response might be stunting growth in millions of kids

April 24, 2018
An overactive immune system during childhood among young people in Ecuador's indigenous Shuar population comes with a cost: stunted growth.

Scientists unearth vital link between fat, immunity and heat regulation

April 24, 2018
Scientists have just made a surprising discovery involving fat and special immune cells that live within it—it turns out that 'gd T cells' are the key cogs in the biological wheel that regulates our body heat and protects ...

Odd one out: Protein goes against the family to prevent cancer

April 23, 2018
Melbourne researchers have made the surprise discovery that the 'odd one out' in a family of proteins known to drive cancer development is instead critical for preventing stomach cancers.

Research debunks 'myth' that strenuous exercise suppresses the immune system

April 20, 2018
New research overturns a myth that has persisted for nearly four decades - that competing in endurance sports, like this weekend's London Marathon, suppresses the body's immune system and makes competitors more susceptible ...

Immune diversity among the KhoeSan population

April 20, 2018
A new study of the KhoeSan of Southern Africa has improved the understanding of immune diversity among the oldest surviving indigenous population in the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.